[1] |
Tsuchiya N,Sawada Y,Endo I, et al. Biomarkers for the early diagnosis of hepatocellular carcinoma[J]. World J Gastroenterol, 2015, 21(37):10573-10583.
|
[2] |
Tomimaru Y,Wada H,Eguchi H, et al. Clinical significance of surgical resection of metastatic lymph nodes from hepatocellular carcinoma[J]. Surg Today, 2015, 45(9): 1112-1120.
|
[3] |
Song T. Recent advances in surgical treatment of hepatocellular carcinoma[J]. Drug Discov Ther, 2015, 9(5): 319-330.
|
[4] |
Pan QX,Su ZJ,Zhang JH, et al. A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer[J]. Onco Targets Ther, 2015, 8: 1375-1385.
|
[5] |
邓国荣,陈博艺,李荣, 等. 中性粒细胞淋巴细胞比率与原发性肝癌预后的相关分析[J/CD]. 消化肿瘤杂志(电子版), 2014, 6(4): 213-216.
|
[6] |
Kayadibi H,Sertoglu E,Uyanik M, et al. Neutrophil-lymphocyte ratio is useful for the prognosis of patients with hepatocellular carcinoma[J]. World J Gastroenterol, 2014, 20(28): 9631-9632.
|
[7] |
Fujiwara N,Tateishi R,Nakagawa H, et al. Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma[J]. Hepatol Res, 2015, 45(6): 645-655.
|
[8] |
Li MX,Bi XY,Li ZY, et al. Prognostic role of Glasgow prognostic score in patients with hepatocellular carcinoma: a systematic review and Meta-analysis[J]. Medicine (Baltimore), 2015, 94(49): e2133.
|
[9] |
Aldemir MN,Turkeli M,Simsek M, et al. Prognostic value of baseline neutrophil-Lymphocyte and platelet-lymphocyte ratios in local and advanced gastric cancer patients[J]. Asian Pac J Cancer Prev, 2015, 16(14): 5933-5937.
|
[10] |
Kilincalp S,Çoban Ş,Akinci H, et al. Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma[J]. Eur J Cancer Prev, 2015, 24(4): 328-333.
|
[11] |
Smith RA,Bosonnet L,Raraty M, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma[J]. Am J Surg, 2009, 197(4): 466-472.
|
[12] |
Hu B,Yang XR,Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20(23): 6212-6222.
|
[13] |
Coupland LA,Parish CR. Platelets, selectins, and the control of tumor metastasis[J]. Semin Oncol, 2014, 41(3): 422-434.
|
[14] |
Quigley DA,Kristensen V. Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells[J]. Mol Oncol, 2015, 9(10): 2054-2062.
|
[15] |
Yang Z,Zhang J,Lu Y, et al. Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization[J]. Oncotarget, 2015, 6(40): 43090-43098.
|
[16] |
Xia W,Ke Q,Wang Y, et al. Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation[J]. World J Surg Oncol, 2015, 13: 60.
|
[17] |
Li X,Chen ZH,Ma XK, et al. Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma[J]. Tumour Biol, 2014, 35(11): 11057-11063.
|
[18] |
Zhang WW,Liu KJ,Hu GL, et al. Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients[J]. Tumour Biol, 2015, 36(11): 8831-8837.
|